Answers are grounded in this paper and cite their sources.
Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a major global health threat due to its rapid dissemination and severely limited treatment options. Here, we report the phenotypic and genomic characterization of an ST656 K. pneumoniae clinical isolate carrying bla OXA-181 in China. Antimicrobial susceptibility testing confirmed carbapenem resistance, whereas the isolate remained susceptible to aztreonam, amikacin and trimethoprim/sulfamethoxazole, with a colistin MIC of ≤0.5 μg/mL. Whole-genome sequencing identified the bla OXA-181 gene on a 51,391-bp ColKP3/IncX3 plasmid co-harboring multiple resistance determinants. Conjugation assays yielded bla OXA-181 -positive transconjugants at a recovery frequency of 2 × 10 −4 . Following serial passage, bla OXA-181 was stably maintained for 100 generations. Comparative genomic analysis showed that the bla OXA-181 -carrying plasmid shared a highly conserved backbone with plasmids from geographically diverse isolates, while KP413706 represents a distinct ST656 lineage. These findings expand the genomic evidence for bla OXA-181 -carrying ST656 K. pneumoniae in China and underscore the urgent need for enhanced genomic surveillance and stringent infection control strategies.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: